EQT to sell Karo Healthcare, a Leading Pan-European Consumer health Platform, to KKR
- Editor
- 6 days ago
- 1 min read
Whats Happening:
EQT VIII fund has agreed to sell Karo Healthcare to KKR. Under EQT's ownership since 2019, Karo has transformed from a Nordic specialty pharma business into a pan-European consumer healthcare platform. The company has quadrupled in sales, completed eight strategic acquisitions, and established a presence in over 90 countries with leading brand positions across European markets.
Key Moves:
EQT VIII fund agrees to sell Karo Healthcare to KKR
Karo transformed from Nordic specialty pharma to pan-European consumer healthcare platform under EQT's ownership
Karo completed eight strategic acquisitions and quadrupled sales during EQT's ownership
By The Numbers:
Karo's sales quadrupled under EQT's ownership
Karo completed 8 strategic acquisitions
Karo now reaches consumers in over 90 countries
Key Quotes:
"We're incredibly proud of what we've achieved in recent years and grateful to EQT for their partnership, which has been instrumental in helping us grow and evolve into the business we are today." - Christoffer Lorenzen, CEO of Karo Healthcare
"Karo is a textbook example of EQT's approach – scaling a local company into a fast-growing sector champion with international reach." - Erika Henriksson, Partner in the EQT Private Equity advisory team
"Karo is a unique platform with high-quality brands, strong digital and commercial capabilities, and a proven strong leadership team." - Inaki Cobo, Partner at KKR
Bottom Line:
The sale of Karo Healthcare to KKR marks a successful exit for EQT VIII fund, showcasing its ability to transform and scale businesses in the consumer healthcare sector. KKR's acquisition signals continued interest in the growing consumer health market, with plans to support Karo's further expansion and innovation.
Comments